Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    May 2017
  1. TAIEB J, Le Malicot K, Shi Q, Penault Lorca F, et al
    Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    February 2017
  2. PICCO G, Petti C, Sassi F, Grillone K, et al
    Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    January 2017
  3. IMPERIALE TF, Yu M, Monahan PO, Stump TE, et al
    Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    September 2016
  4. OSUGA T, Takimoto R, Ono M, Hirakawa M, et al
    Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    August 2016
  5. OSUGA T, Takimoto R, Ono M, Hirakawa M, et al
    Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  6. FERRIS RL, Galon J
    Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  7. ROZEK LS, Schmit SL, Greenson JK, Tomsho LP, et al
    Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    July 2016
  8. TOUGERON D, Mouillet G, Trouilloud I, Lecomte T, et al
    Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  9. HOCHSTER HS, Sargent DJ
    One good DNA-damage deserves another: Oxaliplatin in MSI-high colon cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    June 2016
  10. SINGH S, Earle CC, Bae SJ, Fischer HD, et al
    Incidence of Diabetes in Colorectal Cancer Survivors.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  11. SCHULTHEIS AM, Ng CK, De Filippo MR, Piscuoglio S, et al
    Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    J Natl Cancer Inst. 2016;108:djv427.
    PubMed     Text format     Abstract available


    May 2016
  12. ZHENG Z, Yabroff KR, Guy GP Jr, Han X, et al
    Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  13. COOPER GS, Kou TD, Schluchter MD, Dor A, et al
    Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    April 2016
  14. INAMURA K, Song M, Jung S, Nishihara R, et al
    Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  15. XIE L, Jiang FC, Zhang LM, He WT, et al
    Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  16. ANTONUZZO L, Lunghi A, Giommoni E, Brugia M, et al
    Regorafenib Also Can Cause Osteonecrosis of the Jaw.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    March 2016
  17. WEN-ZHUO H, Liang-Ping X
    RE: A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  18. SCLAFANI F, Cunningham D, Peckitt C, Watkins D, et al
    Response.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  19. GOBBO J, Marcion G, Cordonnier M, Dias AM, et al
    Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  20. SOHAL DP, Rini BI, Khorana AA, Dreicer R, et al
    Prospective Clinical Study of Precision Oncology in Solid Tumors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    February 2016
  21. KASTRINOS F, Ojha RP, Leenen C, Alvero C, et al
    Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  22. KUIPERS EJ, Spaander MC
    Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  23. SALI L, Mascalchi M, Falchini M, Ventura L, et al
    Reduced and Full-Preparation CT Colonography, Fecal Immunochemical Test, and Colonoscopy for Population Screening of Colorectal Cancer: A Randomized Trial.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  24. TUCCORI M, Filion KB, Azoulay L
    RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  25. AIT OUAKRIM D, Dashti SG, Win AK
    Response.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  26. KIM JJ, Tosteson AN, Zauber AG, Sprague BL, et al
    Cancer Models and Real-world Data: Better Together.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  27. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    January 2016
  28. SARTORE-BIANCHI A, Ardini E, Bosotti R, Amatu A, et al
    Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available



  29. Stat Bite Number of New Colorectal Cancer Cases By Race/Ethnicity & Sex (2008-2012).
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  30. FRASER CG, Rapi S, Rubeca T
    RE: A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  31. NGEOW J, Eng C
    Rectal Cancer: Age Matters in the Affairs of Stage.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  32. MEYER JE, Cohen SJ, Ruth KJ, Sigurdson ER, et al
    Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  33. FENICHEL M
    Restoring Apc Gene Function Enables New Avenues of Research.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  34. LIH CJ, Chen AP
    N of 2 Responders with LMNA-NTRK1.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  35. ALFANO CM, Bluethmann SM, Tesauro G, Perna F, et al
    NCI Funding Trends and Priorities in Physical Activity and Energy Balance Research Among Cancer Survivors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  36. BEACHLER DC, Kreimer AR, Schiffman M, Herrero R, et al
    Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  37. TSENG YC, Kulp SK, Lai IL, Hsu EC, et al
    Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
    J Natl Cancer Inst. 2015;107:djv274.
    PubMed     Text format     Abstract available


  38. DUNN BK, Steele VE, Fagerstrom RM, Topp CF, et al
    Predictive Value Tools as an Aid in Chemopreventive Agent Development.
    J Natl Cancer Inst. 2015;107:djv259.
    PubMed     Text format     Abstract available


    November 2015
  39. ALLEGRA CJ, Yothers G, O'Connell MJ, Beart RW, et al
    Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  40. BARTH SD, Schulze JJ, Kuhn T, Raschke E, et al
    Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  41. AN MW, Dong X, Meyers J, Han Y, et al
    Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    June 2015
  42. SANTORO V, Jia R, Thompson H, Nijhuis A, et al
    Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: